Primary breast cancer: Mammographic changes after neoadjuvant chemotherapy, with pathologic correlation

被引:124
作者
Vinnicombe, SJ
MacVicar, AD
Guy, RL
Sloane, JP
Powles, TJ
Knee, G
Husband, JE
机构
[1] ROYAL MARSDEN HOSP,DEPT DIAGNOST RADIOL,SUTTON SM2 5PT,SURREY,ENGLAND
[2] ROYAL MARSDEN HOSP,DEPT PATHOL,SUTTON SM2 5PT,SURREY,ENGLAND
[3] ROYAL MARSDEN HOSP,BREAST UNIT,SUTTON SM2 5PT,SURREY,ENGLAND
关键词
breast neoplasms; calcification; therapy; chemotherapy;
D O I
10.1148/radiology.198.2.8596827
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PURPOSE: To correlate changes depicted at mammography during neoadjuvant chemotherapy for operable breast carcinoma with subsequent pathologic status. MATERIALS AND METHODS: Patients (n = 107) underwent mammography before and after neoadjuvant chemotherapy, prior to surgery. Four retrospectively determined grades of response at mammography included complete, mammographic (decreased size and/or density), stable disease, or progressive disease. RESULTS: In 95 fully assessable patients, grade of response to chemotherapy was complete in eight (9%), mammographic in 78 (82%), stable disease in seven (7%), and progressive disease in two (2%). Before and after treatment, respectively, 64 (67%) and 20 (21%) masses were greater than 2 cm in bidimensional diameter. Response was not complete in any of the 44 (46%) cases of microcalcifications. At histologic examination after surgery in 95 fully assessable patients, five of eight patients with complete response were found to have residual tumor (three with an invasive component); eight were found to have no residual tumor (response in three was complete; in four, mammographic; and in one, stable disease). CONCLUSION: Whereas mammograms in most patients showed some response to chemotherapy, prediction of pathologic outcome was not possible.
引用
收藏
页码:333 / 340
页数:8
相关论文
共 33 条
[11]  
FELDMAN LD, 1986, CANCER RES, V46, P2578
[12]  
FISHER B, 1987, SEMIN ONCOL, V5, P385
[13]  
FORNAGE BD, 1987, CANCER, V60, P765, DOI 10.1002/1097-0142(19870815)60:4<765::AID-CNCR2820600410>3.0.CO
[14]  
2-5
[15]  
HAYWARD JL, 1977, CANCER, V39, P1289, DOI 10.1002/1097-0142(197703)39:3<1289::AID-CNCR2820390340>3.0.CO
[16]  
2-F
[17]  
Hortobagyi G N, 1985, Prog Clin Biol Res, V201, P105
[18]  
HORTOBAGYI GN, 1988, CANCER, V62, P2507, DOI 10.1002/1097-0142(19881215)62:12<2507::AID-CNCR2820621210>3.0.CO
[19]  
2-D
[20]  
HORTOBAGYI GN, 1986, J CLIN ONCOL, V12, P1727